Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.
- 2022-01-10
- Meta-Analysis · n = 1,250
- The Cochrane database of systematic reviews 2022(1)
- Kate E Roberts
- India T Adsett
- Kirsty Rickett
- Sophie M Conroy
- Mark D Chatfield
- Natasha E Woodward
- PubMed: 35005781
- DOI: 10.1002/14651858.cd013167.pub2
- High evidence
- Clinical
Six studies showed a treatment effect with 95% CI that did not include an MCID (vitamin D, testosterone, omega-3 fatty acids, duloxetine, emu oil, cat's claw).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- not specified in abstract